Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03519451 · ClinicalTrials.gov registry record · NA

Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment

A NA study of Depression and Tobacco Use Disorder, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03519451: Active NA study of Depression and Tobacco Use Disorder, sponsored by M.D. Anderson Cancer Center.

NCT03519451 is a NA study of Depression and Tobacco Use Disorder that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 24 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03519451, a NA study of Depression and Tobacco Use Disorder, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well smartphone mobile applications work in enhancing smoking cessation treatment in current smokers. Smartphone mobile applications may help current smokers quit smoking.

Primary Outcome

KickAsh group compliance with mood rating determined by questionnaires, phone calls, and interview.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Internet-Based Intervention

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-04-25
Est. Completion 2026-12-31
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT03519451 still lists

NCT03519451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT03519451 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03519451 about?

NCT03519451 is a clinical study titled "Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment". This trial studies how well smartphone mobile applications work in enhancing smoking cessation treatment in current smokers. Smartphone mobile applications may help current smokers quit smoking.

What is the current status of trial NCT03519451?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2018-04-25. Estimated completion is 2026-12-31.

What conditions does trial NCT03519451 study?

This clinical trial studies the following conditions: Depression, Tobacco Use Disorder, Current Every Day Smoker.

What interventions are being tested in trial NCT03519451?

The interventions under investigation include: Questionnaire Administration (OTHER), Internet-Based Intervention (OTHER).

Who is sponsoring clinical trial NCT03519451?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03519451 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03519451's enrollment target sits among peer trials

24 594th of 679 higher than 79 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT03519451, the US trial registry maintained by the National Library of Medicine. NCT03519451 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.